ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling

BACKGROUND: Lung cancer (LC) is still the most common cause of cancer related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of all LC cases but is not a single entity. It is now accepted that, apart from the characteristic driver mutations, the unique molecular signatures of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesel, M., Rapp, J., Feller, D., Kiss, E., Jaromi, L., Meggyes, M., Miskei, G., Duga, B., Smuk, G., Laszlo, T., Karner, I., Pongracz, J.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364604/
https://www.ncbi.nlm.nih.gov/pubmed/28340578
http://dx.doi.org/10.1186/s12931-017-0537-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364604/
https://www.ncbi.nlm.nih.gov/pubmed/28340578
http://dx.doi.org/10.1186/s12931-017-0537-6

Ejemplares similares